Apollomics (APLM) Cash & Current Investments (2020 - 2025)
Apollomics (APLM) posted quarterly Cash & Current Investments of $3.3 million for Q4 2025, down 66.46% year-on-year from $9.8 million in Q4 2024, and up 56.45% on a QoQ basis from $2.1 million in Q2 2025.
Apollomics (APLM) Cash & Current Investments (2020 - 2025) Analysis & Trends
Apollomics (APLM) has reported Cash & Current Investments for 6 consecutive years, with $3.3 million the latest figure, recorded in Q4 2025.
- Quarterly Cash & Current Investments fell 66.46% year-over-year to $3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (down 66.46% YoY) and the FY2025 annual result came in at $3.3 million, down 66.46% from the prior year.
- Cash & Current Investments advanced to $3.3 million in Q4 2025 per APLM's latest filing, from $2.1 million in the prior quarter.
- Over the last five years, Cash & Current Investments for APLM reached as high as $51.7 million in Q4 2022 and fell as low as $2.1 million in Q2 2025.
- A 5-year average of $28.6 million and a median of $30.2 million in 2021 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments surged 71.16% — and 2025, when it sank 91.92%.
- Year by year, Cash & Current Investments stood at $30.2 million in 2021, then jumped by 71.16% to $51.7 million in 2022, then dropped by 26.91% to $37.8 million in 2023, then sank by 74.18% to $9.8 million in 2024, then sank by 66.46% to $3.3 million in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $3.3 million, $2.1 million, and $9.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.28 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Dec 31, 2024 | 9.77 Mn |
| Jun 30, 2024 | 25.93 Mn |
| Dec 31, 2023 | 37.82 Mn |
| Jun 30, 2023 | 45.70 Mn |
| Dec 31, 2022 | 51.74 Mn |
| Jun 30, 2022 | 50.70 Mn |
| Dec 31, 2021 | 30.23 Mn |
| Dec 31, 2020 | 130.65 Mn |